Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 81 | ECE2022 | Next issue

European Congress of Endocrinology 2022

Milan, Italy
21 May 2022 - 24 May 2022

Card image cap
The 24th European Congress of Endocrinology (ECE) and the Italian Society of Endocrinology look forward to welcoming you to Milan. ECE 2022 returns for a four day, six parallel session festival of endocrine science. You can join us In person in Milan, Italy OR Live @Home online!

Debate Sessions

Adjuvant Radioactive Iodine Therapy for low to intermediate risk differentiated thyroid cancer patients

Previous section
Pituitary adenoma or pituitary tumor?
Table of contents

ea0081d3.1 | Adjuvant Radioactive Iodine Therapy for low to intermediate risk differentiated thyroid cancer patients | ECE2022

Abstract unavailable...
0 shares

ea0081d3.2 | Adjuvant Radioactive Iodine Therapy for low to intermediate risk differentiated thyroid cancer patients | ECE2022

For: Adjuvant radioactive iodine therapy for low to intermediate risk differentiated thyroid cancer patients

Galofre Juan Carlos

Current indications for adjuvant Radioactive Iodine (RAI) in low- and intermediate-risk differentiated thyroid cancer (DTC) are controversial. At the same time, there is universal consensus for personalized DTC management according to individual patient needs, as there does not appear to be a ‘‘right’’ way to treat patients with DTC. According to the Martinique Principles 1, adjuvant RAI treatment has many goals, including: initial stagi...
0 shares

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more